BRANDYWINE MANAGERS, LLC

Holdings History for Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC)

Symbol: FULC on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.17%	$0	0	-26,127	-100%	$10.94	Q3 2024
30 Jun 2024	0.17%	0%	$161,987	26,127	0		$6.20	Q2 2024
31 Mar 2024	0.24%	0%	$246,639	26,127	0		$9.44	Q1 2024
31 Dec 2023	0.19%	0%	$176,357	26,127	0		$6.75	Q4 2023
30 Sep 2023	0.2%	0%	$116,004	26,127	0		$4.44	Q3 2023
30 Jun 2023	0.06%	0%	$86,219	26,127	0		$3.30	Q2 2023
31 Mar 2023	0.05%	0%	$74,462	26,127	0		$2.85	Q1 2023
31 Dec 2022	0.66%	0%	$190,205	26,127	0		$7.28	Q4 2022
30 Sep 2022	0.69%	0%	$211,000	26,127	0		$8.08	Q3 2022
30 Jun 2022	0.31%	0%	$128,000	26,127	0		$4.90	Q2 2022
31 Mar 2022	1.1%	+0.03%	$618,000	26,127	+847	+3.4%	$23.65	Q1 2022
31 Dec 2021	0.51%	+0.1%	$447,000	25,280	+4,892	+24%	$17.68	Q4 2021
30 Sep 2021	0.6%	0%	$575,000	20,388	0		$28.20	Q3 2021
30 Jun 2021	0.24%	0%	$214,000	20,388	0		$10.50	Q2 2021
31 Mar 2021	0.32%	0%	$240,000	20,388	0		$11.77	Q1 2021
31 Dec 2020	0.33%	0%	$239,000	20,388	0		$11.72	Q4 2020
30 Sep 2020	0.59%	+0.14%	$162,000	20,388	+5,000	+32%	$7.95	Q3 2020
30 Jun 2020	1.2%	0%	$281,000	15,388	0		$18.26	Q2 2020
31 Mar 2020	0.06%	+0.02%	$184,000	15,388	+4,000	+35%	$11.96	Q1 2020
31 Dec 2019	0.06%	-0.09%	$189,000	11,388	-18,312	-62%	$16.60	Q4 2019
30 Sep 2019	0.07%	+0.07%	$197,000	29,700	+29,700	NEW	$6.63	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.